Advertisement ProEthic launches Ibudone for acute pain - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ProEthic launches Ibudone for acute pain

ProEthic Pharmaceuticals has launched Ibudone, a new prescription fixed combination of hydrocodone and ibuprofen for the short-term management of acute pain.

Ibudone provides the highest hydrocodone or ibuprofen dosage available, 10mg of hydrocodone/200mg of ibuprofen in each tablet. Peak plasma levels are achieved in less than two hours. Ibudone is also available with 5mg hydrocodone/200mg of ibuprofen.

Carl Whatley, chairman and CEO of ProEthic, said: “By combining 10mg of hydrocodone with ibuprofen, Ibudone offers a powerful new option for relieving acute pain. It is important to note that Ibudone does not have the risk of acetaminophen liver toxicity, a leading cause of acute liver failure in the US. In addition, Ibudone also offers physicians schedule III prescribing convenience, a key issue with today’s busy practices.”